home
Bringing New Horizons to Therapy

 

General News

AURO publishes official guidelines regarding HIFU treatment

 In its latest recommendations, the AURO (Association of Italian Urologists) recommends Ablatherm® HIFU treatment as first-line treatment for localized prostate cancer. This publication coming a year after the publication of similar recommendations by the AFU (French Association of Urology) reinforces the growing place of HIFU in the treatment of prostate cancer.
Print This Page